SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-019730
Filing Date
2020-09-15
Accepted
2020-09-15 14:50:06
Documents
31
Period of Report
2020-09-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20200915_8k.htm 8-K 22473
2 EXHIBIT 99.1 ex_203798.htm EX-99.1 17495
3 a01.jpg GRAPHIC 68348
4 a02.jpg GRAPHIC 159088
5 a03.jpg GRAPHIC 48864
6 a04.jpg GRAPHIC 116476
7 a05.jpg GRAPHIC 58555
8 a06.jpg GRAPHIC 91939
9 a07.jpg GRAPHIC 71438
10 a08.jpg GRAPHIC 55067
11 a09.jpg GRAPHIC 89704
12 a10.jpg GRAPHIC 56553
13 a11.jpg GRAPHIC 57770
14 a12.jpg GRAPHIC 91765
15 a13.jpg GRAPHIC 82084
16 a14.jpg GRAPHIC 75106
17 a15.jpg GRAPHIC 37119
18 a16.jpg GRAPHIC 110177
19 a17.jpg GRAPHIC 50493
20 a18.jpg GRAPHIC 70765
21 a19.jpg GRAPHIC 50251
22 a20.jpg GRAPHIC 43775
23 a21.jpg GRAPHIC 50574
24 a22.jpg GRAPHIC 72818
25 a23.jpg GRAPHIC 78165
26 a24.jpg GRAPHIC 73840
27 a25.jpg GRAPHIC 69851
28 a26.jpg GRAPHIC 72296
29 a27.jpg GRAPHIC 84287
30 a28.jpg GRAPHIC 126295
31 a29.jpg GRAPHIC 31141
  Complete submission text file 0001437749-20-019730.txt   2997792
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 201175801
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences